已确认可信度 84%The FDA[1][4] news release is headed "For Immediate Release: February 12, 2026" and says the FDA "has approved drug labeling changes to six menopausal hormone therapy products".
The FDA approves new labels for six menopausal hormone therapy products, one from each class, that drop the cardiovascular, breast cancer and dementia statements from the boxed warning; 29 companies have filed changes.
KPMG, 8, Salisbury Square, West Smithfield, Blackfriars, City of London, Greater London, England, EC4Y 8AP, United KingdomQualcomm
已确认可信度 89%The tribunal's case page says 'On 13 February 2026, Which? and Qualcomm filed a joint collective settlement approval order ("CSAO") application' and the judgment cites 'the settlement agreement dated 13 February 2026'.[1]
Which? and Qualcomm signed a 'drop hands' settlement ending its UK class action, valued at about GBP 482.5 million, with no money for consumers, and jointly asked the Competition Appeal Tribunal to approve it.